Summary minutes - Meeting 2 of the Blood Products Advisory Committee held at the FDA Bureau of Biologics on December 10 -11 1981. Present Joseph R Bove (Chair) Elizabeth Hafleigh Ronlad Miller William V Millar James Mosley Louis Sullivan John Suttle. Also present were a number of observers. Objective of the meeting was to address whether or not the antiglobulin phase of the major crossmatch should be deleted from the requirement for compatibility testing.